Skip to main content

Table 1 Patient characteristics at baseline (n = 40)

From: Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer

Patient characteristics

Value

Median (range) age, years

63 (54–66)

Gender, n (%)

 

 Male

30 (75.0)

 Female

10 (25.0)

ECOG PS, n (%)

 

 0

20 (50.0

 1

20 (50.0)

TNM status, n (%)

 T3*

32 (80.0)

 T3a

3 (7.5)

 T3b

1 (2.5)

 T3c

2 (5.0)

 T4

2 (5.0)

 Nx

1 (2.5)

 N0

1 (2.5)

 N1

24 (60.0)

 N2

14 (35.0)

  1. *It was not specified if the T3 status was T3a, T3b or T3c.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us